← All Novavax INC filings

Novavax INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
NVAX
Novavax INC
DEF: Novavax Sets June 18th Annual Meeting Date
Novavax, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 18, 2026, with key proposals including director elections and stock plan amendments.
NASDAQ
NVAX
Novavax INC
DEFA14A: Novavax Sets Date for 2025 Annual Stockholder Meeting, Outlines Key Proposals
Novavax has scheduled its annual stockholder meeting for June 20, 2025, and is seeking votes on director elections, executive compensation, and auditor ratification.
NASDAQ
NVAX
Novavax INC
DEF: Novavax Aims for Growth Through Partnerships and Pipeline Expansion: 2025 Proxy Statement Highlights Strategy Shift
Novavax's 2025 proxy statement outlines a strategic shift towards maximizing its technology platform through partnerships and pipeline expansion, moving beyond COVID-19 vaccine commercialization.
NASDAQ
NVAX
Novavax INC
DEFA14A: Novavax Amends Proxy Statement Regarding 2015 Stock Incentive Plan
Novavax amends its definitive proxy statement to clarify non-employee director compensation limits under the Amended 2015 Stock Incentive Plan.
NASDAQ
NVAX
Novavax INC
DEFA14A: Novavax Files Definitive Proxy Statement for Upcoming Shareholder Meeting
Novavax has filed its definitive proxy statement with the SEC, outlining details for its upcoming shareholder meeting.
NASDAQ
NVAX
Novavax INC
DEF 14A: Novavax Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals
Novavax has scheduled its 2024 Annual Meeting of Stockholders for June 13, 2024, featuring proposals ranging from director elections to executive compensation and stock plan amendments.